News & Updates

Peritoneal dialysis not better than haemodialysis for BP control in ESRD

18 Sep 2020

Peritoneal dialysis (PD) poses no clear advantage over haemodialysis (HD) for overall blood pressure (BP) control in end-stage renal disease (ESRD), a recent study has found.

Peritoneal dialysis not better than haemodialysis for BP control in ESRD

18 Sep 2020

Can riociguat REPLACE PDE-5is for PAH?

17 Sep 2020 by

Patients with pulmonary arterial hypertension (PAH) experienced clinical improvement when they switched from a phosphodiesterase type 5 inhibitor (PDE-5i) to riociguat, highlighting the latter’s potential as a treatment alternative in this setting, results of the REPLACE* study have shown.

Can riociguat REPLACE PDE-5is for PAH?

17 Sep 2020

Good midterm outcomes seen in congenital heart disease-related PAH

17 Sep 2020

Patients with congenital heart disease-associated pulmonary artery hypertension (CHD-PAH) have favourable midterm outcomes, a new study reports.

Good midterm outcomes seen in congenital heart disease-related PAH

17 Sep 2020

Cardiovascular risk factors tied to hearing impairment in men

16 Sep 2020

Men with cardiovascular risk factors, hypertension in particular, appear to be at a higher risk of hearing impairment (HI), reports a recent Japan study.

Cardiovascular risk factors tied to hearing impairment in men

16 Sep 2020

High dose comparable to lower doses of ACE inhibitors for heart failure

16 Sep 2020 by

In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.

High dose comparable to lower doses of ACE inhibitors for heart failure

16 Sep 2020

Can coronary plaque EVAPORATE with prescription-grade EPA?

16 Sep 2020 by

The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.

Can coronary plaque EVAPORATE with prescription-grade EPA?

16 Sep 2020

Adulthood weight gain linked to CVD mortality, incidence

15 Sep 2020

Weight gain during adulthood increases the risk of cardiovascular disease (CVD), reports a new meta-analysis.

Adulthood weight gain linked to CVD mortality, incidence

15 Sep 2020

Long naps may increase CVD, all-cause mortality risks

15 Sep 2020 by

Individuals who reported a long nap duration of 60 minutes/day had a higher risk of cardiovascular disease (CVD) and all-cause mortality than those who did not take any daytime naps, according to a study presented at ESC 2020.

Long naps may increase CVD, all-cause mortality risks

15 Sep 2020

Sacubitril–valsartan combo good for kidneys in HFpEF

15 Sep 2020 by

In patients with heart failure with preserved ejection fraction (HFpEF), angiotensin-neprilysin inhibition with sacubitril/valsartan confers better renoprotection than valsartan alone, reducing the risk of adverse renal events and the speed of decline in estimated glomerular filtration rate (eGFR), a study has found.

Sacubitril–valsartan combo good for kidneys in HFpEF

15 Sep 2020

BRACE CORONA advocates continuing ACEis/ARBs in mild-to-moderate COVID-19

14 Sep 2020 by

Patients hospitalized with mild-to-moderate COVID-19 who are on angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for hypertension should continue these medications, according to primary results of the BRACE CORONA trial presented at ESC 2020.

BRACE CORONA advocates continuing ACEis/ARBs in mild-to-moderate COVID-19

14 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Peritoneal dialysis not better than haemodialysis for BP control in ESRD

Peritoneal dialysis not better than haemodialysis for BP control in ESRD

Can riociguat REPLACE PDE-5is for PAH?

Can riociguat REPLACE PDE-5is for PAH?

Good midterm outcomes seen in congenital heart disease-related PAH

Good midterm outcomes seen in congenital heart disease-related PAH

Cardiovascular risk factors tied to hearing impairment in men

Cardiovascular risk factors tied to hearing impairment in men

High dose comparable to lower doses of ACE inhibitors for heart failure

High dose comparable to lower doses of ACE inhibitors for heart failure

Can coronary plaque EVAPORATE with prescription-grade EPA?

Can coronary plaque EVAPORATE with prescription-grade EPA?

Adulthood weight gain linked to CVD mortality, incidence

Adulthood weight gain linked to CVD mortality, incidence

Long naps may increase CVD, all-cause mortality risks

Long naps may increase CVD, all-cause mortality risks

Sacubitril–valsartan combo good for kidneys in HFpEF

Sacubitril–valsartan combo good for kidneys in HFpEF

BRACE CORONA advocates continuing ACEis/ARBs in mild-to-moderate COVID-19

BRACE CORONA advocates continuing ACEis/ARBs in mild-to-moderate COVID-19